Health Care/Hospital
Amai Proteins succesfully completed world's first human clinical trial on effects of sweet proteins, with sweelin®
REHOVOT, Israel, Dec. 17, 2024 /PRNewswire/ -- Amai Proteins
2024-12-17 09:00
1089
DID YOU HAVE A HIP, KNEE, OR OTHER JOINT REPLACEMENT?
If your implant/replacement involved Exactech products – including Optetrak, Optetrak Logic, Truliant, Vantage, Connexion GXL, and Equinoxe – your attention to this notice is important. NEW YORK, Dec. 17, 2024 /PRNewswire/ -- The following is being issued by Kroll Restructuring Administration L...
2024-12-17 00:13
1147
Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg
– Both pivotal studies achieved primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies with high statistical significance (p<0.0001) – Approximately 50% of patients in BROADWAY (Obicetrapib monotherapy) and over 70% of patients in TANDEM (Fixed Do...
2024-12-16 22:08
1599
World's 1st Stem Cell Book on Animals, Reveals How to Extend the Lives of Pets
KOTA KINABALU, Malaysia, Dec. 16, 2024 /PRNewswire/ -- A groundbreaking new
book by Professor Dr.Mike Chan, "STEM CELLS, PEPTIDES & IMMUNOTHERAPY: Handbook
on Regenerative Medicine for Animals,"
2024-12-16 22:00
2264
Everise Expands and Diversifies Its Healthcare Services Portfolio With the Acquisition of Continuum Global Solutions' Vertical
The acquisition strengthens Everise's position as a leading end-to-end healthcare experience provider PLANTATION, Fla., Dec. 16, 2024 /PRNewswire/ -- Everise, a global healthcare customer experience leader, today announced the successful completion of its acquisition of customer experience manag...
2024-12-16 21:00
2833
Perennial General Hospital Tianjin, China's First Wholly Foreign-Owned Private Tertiary General Hospital Will Soon Commence Operations
SINGAPORE, Dec. 16, 2024 /PRNewswire/ -- Perennial Holdings Private Limited (" Perennial Holdings") is pleased to announce that Perennial General Hospital in Tianjin city ("Perennial General Hospital Tianjin"), China, has become the country's first wholly foreign-owned private tertiary general hos...
2024-12-16 19:37
2390
Meeting Baby's Nutritional Needs: Exploring How a2 Milk Powder Enhances Absorption
SHANGHAI, Dec. 16, 2024 /PRNewswire/ -- The a2® Platinum Milk Powder has been upgraded, signifying the brand's continuous innovation and progress in the field of infant nutrition. The a2®Milk Limited, a premium brand in dairy nutrition, focuses on products containing the A2 beta-casein type, anno...
2024-12-16 18:05
1251
HiRO Forges Strategic Partnership with CHA University Bundang Medical Center in South Korea
SEOUL, South Korea, Dec. 16, 2024 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a boutique globalclinical research organization (CRO) providing cross-border clinical trial solutions, proudly announces the signing of a Memorandum of Understanding (MOU) with CHA University Bundan...
2024-12-16 10:30
1693
Take Charge of Your Health with Genuine USANA Products
SALT LAKE CITY, Dec. 16, 2024 /PRNewswire/ -- USANA Health Sciences is a leader in providing quality health supplements, foods and energy products, and skincare solutions to customers around the world. Unfortunately, counterfeit USANA products may find their way to online retailers that do not ca...
2024-12-16 08:46
1036
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China
SAN FRANCISCO and SUZHOU, China, Dec. 16, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
2024-12-16 07:55
2347
Arsana Foundation Collaborates with Om Ham Retreat & Resort to Launch Transformative 200hr Kundalini Tantra Yoga Teacher Training in 2025
BALI, Indonesia, Dec. 16, 2024 /PRNewswire/ -- Arsana Foundation
2024-12-16 07:00
2299
Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-time Delivery, Sustainability, and Competitive Costs
Bushu Pharma's ongoing investments and efforts offer customers state-of-the-art capabilities, increased capacity, and innovative solutions, providing top-tier pharmaceutical manufacturing and supply chain management services. SAN ANTONIO, Dec. 15, 2024 /PRNewswire/ -- Frost & Sullivan researched ...
2024-12-15 13:30
1880
Alphamab Oncology Presented the Phase II Clinical Data of KN046 in Combination with Axitinib for the Treatment of Advanced NSCLC at ESMO IO Congress 2024
SUZHOU, China, Dec. 13, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from a phase II clinical study on PD-L1/CTLA-4 bispecific antibody KN046 in combination with axitinib as first-line treatment for advanced non-small cell lung cancer (NSCLC...
2024-12-13 10:35
2244
Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS
PRINCETON, N.J. and SUZHOU, China, Dec. 13, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, ann...
2024-12-13 08:00
1584
Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian Conference in Hong Kong
92% Diagnostic Accuracy with a Simple Blood Test for Early Diagnosis and Treatment of Endometriosis HONG KONG, Dec. 13, 2024 /PRNewswire/ -- Heranova, a leader in women's health innovation, is excited to announce the launch of HerResolve™, a groundbreaking non-invasive test for endometriosis, at...
2024-12-13 08:00
2333
2024 SABCS｜Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis
YANTAI, China, Dec. 13, 2024 /PRNewswire/ -- On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),RemeGen Co. Ltd. ("RemeGen") (9995.HK, 688331.SH) presented for the first time the data from ...
2024-12-13 07:20
774
DID YOU HAVE A HIP, KNEE, OR OTHER JOINT REPLACEMENT?
If your implant/replacement involved Exactech products – including Optetrak, Optetrak Logic, Truliant, Vantage, Connexion GXL, and Equinoxe – your attention to this notice is important. NEW YORK, Dec. 12, 2024 /PRNewswire/ -- The following is being issued by Kroll Restructuring Administration L...
2024-12-12 23:19
1499
Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital
- A Milestone in Preventive Healthcare and Technological Innovation in Long An TÂN AN CITY, Vietnam, Dec. 12, 2024 /PRNewswire/ -- Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to developVietnam's first AI x ESG Hospital, marking a significant milestone...
2024-12-12 21:23
2018
Xinhua Silk Road: Pien Tze Huang boosts TCM globalization
BEIJING, Dec. 12, 2024 /PRNewswire/ -- Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd., aFujian-based traditional Chinese medicine (TCM) company, has been striving to expand its overseas markets, enhancing the influence of TCM in regions such asSoutheast Asia and Europe. Committed to deepening...
2024-12-12 20:43
1859
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
* ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer withESR1 mutations, aiming to delay disease progression. * The study was presented by the Menarini Group and MEDSIR at the San Ant...
2024-12-12 18:07
1638
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 335 media titles]
2025-01-18 03:30
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 309 media titles]
2025-01-18 17:00
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 306 media titles]
2025-01-21 16:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 306 media titles]
2025-01-20 14:27
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
[Picked up by 303 media titles]
2025-01-22 15:38
Most Read
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
2025-01-18 03:30
11242
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
2025-01-18 17:00
10212
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins
2025-01-17 22:46
9602
Dongying's vibrant Spring Festival awaits visitors
2025-01-17 21:46
9498